Despite the availability of a wide range of glucose‐lowering therapies many patients with type 2 diabetes mellitus (T2DM) need insulin therapy because of progressive pancreatic β‐cell failure.1, 2, 3, 4. Here, INS is linked to type 2 diabetes mellitus.